Eli Lilly makes the best-selling GLP-1 drug, and sales are accelerating.

Use of GLP-1 weight-loss drugs in the U.S. has tripled since 2024.

The share of U.S. adults taking GLP-1 medications to lose weight has reached a record 11%. That's about 40 million people—as ...

FDA accepts two applications for generic weight loss drugs amid international competition as well as issues of patents and ...

Over 4,400 lawsuits target Ozempic and GLP-1 drugs for GI injuries, vision loss, and "Ozempic face." Usage stats, shortages, ...

Medicare previously covered GLP-1s only if the beneficiary also had a condition such as diabetes, sleep apnea, high blood ...

In contrast, one research trial using GLP-1 drugs on obese research subjects did not show a benefit from GLP-1 in the ...

The percentage of American adults who are currently taking a GLP-1 drug for weight loss is 11%, according to a new survey ...

Following the US FDA approval of GLP-1 RA drugs for weight loss, exposures reported to US poison centers increased.

As millions of Americans search for affordable GLP-1 access online, Ozari Health has published a full transparency ...

The pharmaceutical industry is entering a new era where biology and artificial intelligence are converging. Drug discovery, ...

By Andrew Silver SHANGHAI, July 9 (Reuters) - China will add a second GLP-1 drug, used to treat diabetes, to a list of ...